Neutral
Innovative Cellular Therapeutics (LYEL) crosses 12.3% ownership after milestone
Innovative Cellular Therapeutics Holdings Limited has reported beneficial ownership of 3,000,000 shares of Lyell Immunopharma (LYEL) common stock, rep...